4th Quarter - Report
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH for INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Manufacturing of cell and gene therapies; creating an Accelerated Medicines Project cell-based therapy consortium to focus on addressing challenges in the scaling up and out of pluripotent stem cell-based therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TYLER LAMB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.